Overview
Status
Active
Registry date
2021-04-29
Share capital
5 000,00 PLN
Registered address
ul. Świętojańska 43/23, 81-391 Gdynia, Poland
Financials
Revenue history
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 3 of 3 financial statements were filed late (the longest delay 598 days for 2021).
- 2024not filed
- 202323/06/2025
- 202215/04/2024
- 202104/03/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Robert Klimek – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations of will and sign on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $1,350.62 | 100% |
Beneficial owners
No beneficial owners recorded for the company Griinn.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Livistosp. z o.o. | $17,956,135.04 | livisto.pl | ||
| ODA Medicalsp. z o.o. | $9,414,794.43 | odamedical.pl | ||
| Diather Petrusewiczsp. k. | $6,475,149.95 | diather.pl | ||
| Medmess Kropaczewskisp. k. | $4,516,614.15 | medmess.pl | ||
| Vet-Animalsp. z o.o. | $3,655,323.77 | vet-animal.pl | ||
| Mikamedsp. z o.o. | $1,938,472.05 | mikamed.pl | ||
| Beauty Care Solutionsp. z o.o. | $391,209.94 | ohhira.pl | ||
| Beautyeurope.Eu sp. z o.o.sp. k. | $252,179.36 | beautyeurope.eu | ||
| Beokasp. z o.o. | – | beoka.pl | ||
| Biodermaticsp. j. | – | biodermatic.com |
FAQ
The main business activity of Griinn focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on April 29, 2021.
The headquarters is located at: ul. Świętojańska 43, 81-391 Gdynia.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
Last updated: 2026-10-07